Clinical Trials · NCT00987168
Sandostatine® LP and Hyperinsulinism
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Enrollment
- 10
- Start date
- May 2009
- Locations
- 1 site, France
- Primary endpoint
- Glycemia > or equal to 3 mmol/L, before and after 4 meals +Midnight + 4 am